Skip to main content

MoneyWorks4Me

Lupin recalls Duloxetine delayed-release capsules from US market

08 Dec 2017 Evaluate

Lupin is recalling 1.11 lakh units of Duloxetine delayed-release capsules from the US market. The company is recalling 1,11,648 units of Duloxetine delayed-release capsules USP, in the strength of 30 mg, on account of failed dissolution specification. The drug was manufactured by Lupin in Goa plant. The ongoing voluntary nationwide recall is a class III recall.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Peers
Company Name CMP
Sun Pharma. Inds. 1870.05
Dr. Reddys Labs. 1387.00
Cipla 1383.00
Lupin 1953.90
Zydus Lifesciences 1202.70
View more..